Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration.
暂无分享,去创建一个
Milica Radisic | Kai Kang | Ren-Ke Li | M. Radisic | Shu‐hong Li | Jun Wu | R. Weisel | Ren-Ke Li | T. Yau | Richard D Weisel | Yun Xiao | Terrence M Yau | Shu-Hong Li | Jun Wu | Jian Guo | Yun Xiao | K. Kang | Lu Sun | Shu-Ling Jiang | Lei Yang | Lu Sun | Jian Guo | Shu Jiang | Lei Yang
[1] J. Isner,et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. , 1995, Circulation.
[2] W. Stetler-Stevenson,et al. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. , 1997, Circulation.
[3] N. Maruyama,et al. Expression and structure of senescence marker protein-30 (SMP30) and its biological significance , 1999, Mechanisms of Ageing and Development.
[4] Hyun Chul Lee,et al. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.
[5] J. Isner,et al. Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia , 2000, Circulation.
[6] David J. Mooney,et al. Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.
[7] M. Komeda,et al. Initial Effects of the Left Ventricular Repair by Plication May Not Last Long in a Rat Ischemic Cardiomyopathy Model , 2001, Circulation.
[8] YoshihikoSaito,et al. Initial Effects of the Left Ventricular Repair by Plication May Not Last Long in a Rat Ischemic Cardiomyopathy Model , 2001 .
[9] Ren-Ke Li,et al. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. , 2002, The Journal of thoracic and cardiovascular surgery.
[10] M. Komeda,et al. Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study , 2002, Circulation.
[11] M. Komeda,et al. Angiotensin-Converting Enzyme Inhibitor Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair in Rats , 2002, Circulation.
[12] Ren-Ke Li,et al. Improved Left Ventricular Aneurysm Repair With Bioengineered Vascular Smooth Muscle Grafts , 2003, Circulation.
[13] 松林 景二,et al. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts , 2003 .
[14] Stefanie Dimmeler,et al. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. , 2004, Circulation.
[15] M. Komeda,et al. Atrial Natriuretic Peptide Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair , 2004, Circulation.
[16] Stefanie Dimmeler,et al. Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease , 2004, Circulation.
[17] S. Fazel,et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. , 2005, American Journal of Physiology. Heart and Circulatory Physiology.
[18] Dai Fukumura,et al. Engineering vascularized tissue , 2005, Nature Biotechnology.
[19] Narutoshi Hibino,et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. , 2005, The Journal of thoracic and cardiovascular surgery.
[20] Fen Chen,et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. , 2006, Tissue engineering.
[21] J. Toguchida,et al. Expression of the p16INK4A Gene Is Associated Closely with Senescence of Human Mesenchymal Stem Cells and Is Potentially Silenced by DNA Methylation During In Vitro Expansion , 2007, Stem cells.
[22] Stephen F Badylak,et al. The extracellular matrix as a biologic scaffold material. , 2007, Biomaterials.
[23] M. Radisic,et al. Pulsatile perfusion bioreactor for cardiac tissue engineering , 2008, Biotechnology progress.
[24] M. Komeda,et al. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery. , 2008, The Journal of thoracic and cardiovascular surgery.
[25] Christopher M O'Connor,et al. Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.
[26] R. Guyton,et al. Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. , 2010, Journal of the American College of Cardiology.
[27] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[28] Jun Wu,et al. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. , 2010, Biomaterials.
[29] Milica Radisic,et al. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. , 2010, Biomaterials.
[30] D. Burkhoff,et al. Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy. , 2010, The Journal of thoracic and cardiovascular surgery.
[31] S. Wutzler,et al. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network--a future therapy for ischemically challenged tissue. , 2011, The Journal of surgical research.
[32] Milica Radisic,et al. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. , 2011, Biomaterials.
[33] Stephen F Badylak,et al. RETRACTED: Engineered whole organs and complex tissues , 2012, The Lancet.